The global coronary stent market size was valued at USD 7.02 billion in 2025 and is projected to grow from USD 7.38 billion in 2026 to USD 12.26 billion by 2034, exhibiting a CAGR of 6.54% during the forecast period.

The Coronary Stent Market is experiencing rapid expansion driven by the rising prevalence of cardiovascular diseases and technological advancements in minimally invasive interventional cardiology procedures globally.

Market Overview

The coronary stent market plays a crucial role in modern cardiovascular care, providing life-saving solutions for patients suffering from coronary artery diseases. Coronary stents are small, expandable mesh tubes used during percutaneous coronary interventions to restore adequate blood flow through blocked or narrowed arteries, minimizing myocardial infarction risks and improving patient outcomes worldwide.

Market Insights

Market insights indicate substantial commercial potential across various segments. North America currently leads the global landscape, accounting for a 33.55% market share in 2025 with a valuation of USD 2.35 billion, while the Asia Pacific and European regions continue to register strong adoption rates backed by improving healthcare infrastructure and expanding cardiology services.

Market Trends

• Continuous innovations and enhancements in coronary stenting devices, focusing on reduced strut thickness and superior deliverability.
• Growing preference for bioresorbable and advanced drug-eluting stents with biodegradable polymers to minimize long-term vascular complications.
• Expansion of digital integration and AI-assisted planning in cardiac catheterization laboratories.

For detailed market insights, visit the Coronary Stent Market reports: https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065

Market Growth Factors

• Rising global prevalence of coronary heart disorders attributed to sedentary lifestyles, unhealthy dietary habits, and aging demographics.
• Ongoing technological advancements and frequent regulatory approvals for next-generation drug-eluting and self-expandable stents.
• Increasing preference for minimally invasive percutaneous coronary intervention over traditional open-heart surgical procedures.

For request sample reports: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/coronary-stents-market-100065

Competitor Analysis

The global competitive landscape is highly fragmented, featuring major medical device manufacturers such as Medtronic, Boston Scientific Corporation, Abbott, BIOTRONIK SE & Co. KG, and Stentys S.A. Key industry players focus on strategic product approvals, research and development investments, and geographic expansion to strengthen their market positioning and competitive edge.

Segmentation Analysis

The market is broadly categorized by stent type into drug-eluting stents, covered stents, bare metal stents, bioresorbable stents, and others, with drug-eluting stents holding the largest market share. Additional segmentation includes material type (metal and polymer), deployment (self-expandable and balloon-expandable), application (acute and chronic coronary syndromes), and end-users (hospitals, ambulatory surgical centers, and specialty clinics).